Overall, our results demonstrated that the Cy7-1/PG5-Cy5@LWHA nanoprobe entered CD44+ breast cancer cells through CD44-mediated endocytosis, and later localized to the endolysosomal compartments in the cytoplasm. The gene discussed is CD44; the disease is breast carcinoma.